Notice of Effectiveness
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: October 13, 2022
Accession Number: 0001213900-22-062795
Submission Type: POS AM
CIK: 0001788028
Company Name: Jasper Therapeutics, Inc.
File Number: 333-260306